Therapeutic effects of exogenous surfactant enriched with dextran in newborn rabbits with respiratory failure induced by airway instillation of albumin.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Pulmonary Pharmacology & Therapeutics

• Publication date

  2008-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.PUPT.2007.10.003PMID 18032077
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bronchoalveolar lavage with pulmonary surfactant/dextran mixture improves meconium clearance and lung functions in experimental meconium aspiration syndrome

  2008cited by this paper
• Inhibition of pulmonary surfactant adsorption by serum and the mechanisms of reversal by hydrophilic polymers: theory.

  2005cited by this paper
• Biophysical and Physiological Properties of Porcine Surfactant Enriched with Polymyxin B

  2005cited by this paper
• Dextran or Polyethylene Glycol Added to Curosurf for Treatment of Meconium Lung Injury in Rats

  2005cited by this paper
• Biochemical effects of molecular crowding

  2004cited by this paper
• Biochemical effects of molecular crowding

  2004cited by this paper
• Modified Protocols for Surfactant Therapy in Experimental Meconium Aspiration Syndrome

  2003cited by this paper
• Aerosolized surfactant and dextran for experimental acute respiratory distress syndrome caused by acidified milk in rats

  2003cited by this paper
• Neonatal Hair Analysis for Benzoylecgonine: A Sensitive and Semiquantitative Biological Marker for Chronic Gestational Cocaine Exposure

  2002cited by this paper
• The effect of dextran to restore the activity of pulmonary surfactant inhibited by albumin.

  2002cited by this paper
• Bulk shear viscosities of endogenous and exogenous lung surfactants.

  2002cited by this paper
• Overcoming surfactant inhibition with polymers

  2000cited by this paper
• Dextran reduces surfactant inhibition by meconium

  2000cited by this paper
• Dextran restores albumin-inhibited surface activity of pulmonary surfactant extract.

  1999cited by this paper
• Computerized image analysis of lung expansion patterns in surfactant treated immature newborn rabbits.

  1999cited by this paper
• Bolus dispersal through the lungs in surfactant replacement therapy.

  1999cited by this paper
• Nonionic polymers reverse inactivation of surfactant by meconium and other substances.

  1999cited by this paper
• Sensitivity of synthetic surfactants to albumin inhibition in preterm rabbits.

  1999cited by this paper
• Biophysical and physiological properties of a modified porcine surfactant enriched with surfactant protein A.

  1997cited by this paper
• Aggregation of phospholipid vesicles by water-soluble polymers.

  1996cited by this paper
• Surfactant therapy for lung disease

  1995cited by this paper
• Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.

  1993cited by this paper
• Inactivation of Exogenous Surfactant by Pulmonary Edema Fluid

  1991cited by this paper
• Structural and Functional Characterization of Porcine Surfactant Isolated by Liquid-Gel Chromatography1

  1990cited by this paper
• Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro.

  1990cited by this paper
• A biophysical mechanism by which plasma proteins inhibit lung surfactant activity.

  1988cited by this paper
• Interactions between plasma proteins and pulmonary surfactant: surface balance studies.

  1988cited by this paper
• Quantitative evaluation of neonatal lung expansion with automated image analysis.

  1986cited by this paper
• Surface property changes from interactions of albumin with natural lung surfactant and extracted lung lipids.

  1985cited by this paper
• Principles and methods for the morphometric study of the lung and other organs.

  1963cited by this paper

• Surfactant as a drug carrier.

  2023cites this paper
• Pulmonary Surfactant: A Mighty Thin Film.

  2023cites this paper
• Inhibition and counterinhibition of Surfacen, a clinical lung surfactant of natural origin

  2018cites this paper
• Dynamic tensiometry studies on interactions of novel therapeutic inhalable powders with model pulmonary surfactant at the air–water interface

  2015cites this paper
• An update on clinical surfactant preparations and respiratory disease

  2012cites this paper
• New Surfactant with SP-B and C Analogs Gives Survival Benefit after Inactivation in Preterm Lambs

  2012cites this paper
• Surfactant and its Role in the Upper Respiratory System and Eustachian Tube

  2012cites this paper
• Evaluation of Surfactant Function: In Vitro and In Vivo Techniques in Experimental Respirology

  2011cites this paper
• Current perspectives in pulmonary surfactant--inhibition, enhancement and evaluation.

  2008cites this paper
• Current perspectives inpulmonary surfactant — Inhibition , enhancement andevaluation

  2008cites this paper